Targeting the hepcidin-ferroportin pathway by inhibiting the bone morphogenic protein BMP6, which stimulates hepcidin expression in the liver or the iron exporter ferroportin via the monoclonal antibodies, LY3113593 and LY2928057, has not been further investigated beyond a phase 1 study (177)
10.1177/2040620712450252 77 JonesC.BarreraI.BrothersS.RingR.WahlestedtC
Through Peptides Explained, John combines frontline clinical experience with evidence-based scientific analysis to make peptide science more understandable for everyday listeners
Dementia Dementia is a disease most commonly presenting in the elderly, and may be exacerbated by vitamin B12 deficiency
(CTT) Collaborators, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, The Lancet , vol
Mega dose of vitamin C augments the nephrotoxicity of paracetamol